Current Report Filing (8-k)
March 20 2020 - 6:04AM
Edgar (US Regulatory)
0000816956
false
0000816956
2020-03-19
2020-03-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 19, 2020
CONMED CORPORATION
(Exact name of registrant as specified in its
charter)
|
New York
|
|
0-16093
|
|
16-0977505
|
|
(State or other jurisdiction of
|
|
(Commission
|
|
(I.R.S. Employer
|
|
incorporation or organization)
|
|
File Number)
|
|
Identification No.)
|
525 French Road
Utica, New York 13502
(Address of principal executive offices, including
zip code)
(315) 797-8375
(Registrant's telephone number, including area
code)
Securities registered pursuant to Rule 12(b)
of the Act
|
Title of each class
|
|
Trading Symbol
|
|
Name of each exchange on which
registered
|
|
|
|
|
|
|
|
Common Stock, $0.01 par value
|
|
CNMD
|
|
NYSE
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction
A.2 below):
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
As a result of the escalating COVID-19 (coronavirus) pandemic, CONMED
Corporation is withdrawing its previously issued first quarter and full-year 2020 financial guidance. The Company’s
prior financial guidance was based on the estimated impact as of the date of issuance, March 10, 2020. At that time, the
impact of COVID-19 was principally confined to Asia and Europe. In recent days, the pandemic has expanded further into Europe
and the United States, limiting the Company’s ability to estimate the specific impact on its business operations or financial
results for the first quarter and full-year 2020. The Company anticipates that it may experience material disruption to its
financial results for the first quarter and full-year 2020 as a result of the ongoing spread of COVID-19.
|
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
The following exhibit is included herewith:
|
|
Exhibit No.
|
Description
|
|
|
|
|
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
CONMED CORPORATION
|
|
|
(Registrant)
|
|
|
|
|
|
|
By:
|
/s/ Todd W. Garner
|
|
|
Name:
|
Todd W. Garner
|
|
|
Title:
|
Executive Vice President, Chief Financial Officer
|
Date: March 19, 2020
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Jul 2024 to Aug 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Aug 2023 to Aug 2024
